Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas

doi 10.21236/ada591162

Full Text

Abstract

Available in

Date

Authors

Publisher

Defense Technical Information Center

Related search

Imatinib Mesylate for Plexiform Neurofibromas in Patients With Neurofibromatosis Type 1: A Phase 2 Trial

The Lancet Oncology
Oncology
2012English

Management of Head and Neck Plexiform Neurofibromas in Pediatric Patients With Neurofibromatosis Type 1

Archives of Otolaryngology–Head & Neck Surgery
2005English

Multiple Plexiform Neurofibromas in Neurofibromatosis Type 1: A Case Report

Journal of Medical Science And clinical Research
2018Breton

Toward a Survey of Somatic Mutation of the NF1 Gene in Benign Neurofibromas of Patients With Neurofibromatosis Type 1

American Journal of Human Genetics
Genetics
2000English

Craniofacial Plexiform Neurofibromatosis

Journal of Contemporary Dentistry
2018English

Imatinib (STI-571) Heals a Gastrocutaneous Fistula Resulting From a Malignant Gastric Stromal Tumor

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2003English

Neurofibromatosis Type 1 (NF1)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Micro-Rna Response to Imatinib Mesylate in Patients With Chronic Myeloid Leukemia

Haematologica
Hematology
2010English

Massive Pediatric Facial Plexiform Neurofibromatosis in Iraq

Journal of Dentistry Oral Disorders and Therapy
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy